Background: Tracheobronchopulmonary carcinoid tumors are rare neuroendocrine neoplasm, which account for 1% to 2% of all lung malignancies, ranging from low-grade tumors with a long life expectancy (typical carcinoid tumors: TC) to intermediate-differentiation tumors with a more aggressive clinical course (atypical carcinoid tumors: AC).